D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 42 Citations 5,673 114 World Ranking 12074 National Ranking 544

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Amino acid
  • Biochemistry

Florian Nachon mainly focuses on Acetylcholinesterase, Butyrylcholinesterase, Stereochemistry, Nerve agent and Cholinesterase. His work carried out in the field of Butyrylcholinesterase brings together such families of science as Hydrolase, Drug discovery and Active site. His Stereochemistry study combines topics from a wide range of disciplines, such as Tabun, Oxime and Tacrine.

His Nerve agent research incorporates elements of Soman, Adduct, Organophosphate poisoning, Aché and Pharmacology. His Cholinesterase research focuses on subjects like Oxyanion hole, which are linked to Organophosphorus compound and Active center. Many of his research projects under Enzyme are closely connected to Torpedo with Torpedo, tying the diverse disciplines of science together.

His most cited work include:

  • Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. (554 citations)
  • Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents (208 citations)
  • Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase. (185 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Acetylcholinesterase, Butyrylcholinesterase, Stereochemistry, Biochemistry and Nerve agent. His work on Tabun as part of general Acetylcholinesterase research is frequently linked to Torpedo, thereby connecting diverse disciplines of science. His study in Butyrylcholinesterase is interdisciplinary in nature, drawing from both Cholinergic, Cholinesterase, Neuroprotection, Adduct and Chromatography.

His research integrates issues of Soman, Hydrolase, Catalysis, Active site and Substrate in his study of Stereochemistry. The study incorporates disciplines such as Combinatorial chemistry and Pralidoxime in addition to Nerve agent. In his study, In vivo is strongly linked to In vitro, which falls under the umbrella field of Enzyme.

He most often published in these fields:

  • Acetylcholinesterase (51.32%)
  • Butyrylcholinesterase (48.68%)
  • Stereochemistry (38.82%)

What were the highlights of his more recent work (between 2015-2021)?

  • Acetylcholinesterase (51.32%)
  • Butyrylcholinesterase (48.68%)
  • Pharmacology (15.13%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Acetylcholinesterase, Butyrylcholinesterase, Pharmacology, Nerve agent and Biochemistry. Florian Nachon combines subjects such as Oxime, Biophysics and Stereochemistry with his study of Acetylcholinesterase. His Conformational change study, which is part of a larger body of work in Stereochemistry, is frequently linked to Solvation shell, bridging the gap between disciplines.

His Butyrylcholinesterase research integrates issues from Cholinergic, Cholinesterase, Hydrolase, Neuroprotection and Drug discovery. His Nerve agent research includes elements of Bifunctional, Pralidoxime, In vitro and Combinatorial chemistry. His research in the fields of Structure–activity relationship, Catalysis and Endogeny overlaps with other disciplines such as Prokaryotic expression.

Between 2015 and 2021, his most popular works were:

  • Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning (66 citations)
  • Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening (61 citations)
  • Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study. (56 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Amino acid
  • Biochemistry

Florian Nachon mostly deals with Acetylcholinesterase, Butyrylcholinesterase, Biochemistry, Oxime and Stereochemistry. His study looks at the relationship between Acetylcholinesterase and topics such as Biophysics, which overlap with Active site. His Butyrylcholinesterase research is multidisciplinary, incorporating perspectives in Cholinergic, Cholinesterase, Hydrolase, Neuroprotection and Drug discovery.

His Agonist, σ1 receptor, Indole test and Receptor study in the realm of Biochemistry interacts with subjects such as Torpedo. His Oxime study integrates concerns from other disciplines, such as Cyclosarin, Tabun, Sarin, Paraoxon and Pralidoxime. His work deals with themes such as Covalent bond and Protein structure, which intersect with Stereochemistry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.

Yvain Nicolet;Oksana Lockridge;Patrick Masson;Juan C. Fontecilla-Camps.
Journal of Biological Chemistry (2003)

739 Citations

Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents

Guillaume Mercey;Guillaume Mercey;Tristan Verdelet;Tristan Verdelet;Julien Renou;Julien Renou;Maria Kliachyna.
Accounts of Chemical Research (2012)

298 Citations

Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase.

Florian Nachon;Eugénie Carletti;Cyril Ronco;Marie Trovaslet.
Biochemical Journal (2013)

252 Citations

Progress in the development of enzyme-based nerve agent bioscavengers ☆

Florian Nachon;Xavier Brazzolotto;Marie Trovaslet;Patrick Masson;Patrick Masson.
Chemico-Biological Interactions (2013)

154 Citations

Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.

Florian Nachon;Yvain Nicolet;Nathalie Viguié;Patrick Masson.
FEBS Journal (2002)

151 Citations

Aging of Cholinesterases Phosphylated by Tabun Proceeds through O-Dealkylation.

Eugénie Carletti;He Li;Bin Li;Fredrik Ekström.
Journal of the American Chemical Society (2008)

117 Citations

Role of Water in Aging of Human Butyrylcholinesterase Inhibited by Echothiophate: The Crystal Structure Suggests Two Alternative Mechanisms of Aging

Florian Nachon;Oluwatoyin A. Asojo;Gloria E. O. Borgstahl;Patrick Masson.
Biochemistry (2005)

115 Citations

First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase.

Guillaume Mercey;Guillaume Mercey;Tristan Verdelet;Tristan Verdelet;Géraldine Saint-André;Emilie Gillon.
Chemical Communications (2011)

110 Citations

Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation.

Eugénie Carletti;Jacques-Philippe Colletier;Florine Dupeux;Marie Trovaslet.
Journal of Medicinal Chemistry (2010)

104 Citations

Binding and Hydrolysis of Soman by Human Serum Albumin

Bin Li;Florian Nachon;Marie Thérèse Froment;Laurent Verdier.
Chemical Research in Toxicology (2008)

103 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Florian Nachon

Kamil Kuca

Kamil Kuca

University of Hradec Králové

Publications: 99

Patrick Masson

Patrick Masson

Kazan Federal University

Publications: 89

Oksana Lockridge

Oksana Lockridge

University of Nebraska Medical Center

Publications: 60

Franz Worek

Franz Worek

Ludwig-Maximilians-Universität München

Publications: 51

Horst Thiermann

Horst Thiermann

Ludwig-Maximilians-Universität München

Publications: 44

Chang-Guo Zhan

Chang-Guo Zhan

University of Kentucky

Publications: 39

Palmer Taylor

Palmer Taylor

University of Montana

Publications: 30

Manuela Bartolini

Manuela Bartolini

University of Bologna

Publications: 26

Gokhan Zengin

Gokhan Zengin

Selçuk University

Publications: 25

Pierre-Yves Renard

Pierre-Yves Renard

Centre national de la recherche scientifique, CNRS

Publications: 24

Israel Silman

Israel Silman

Weizmann Institute of Science

Publications: 20

Joel L. Sussman

Joel L. Sussman

Weizmann Institute of Science

Publications: 19

Vincenza Andrisano

Vincenza Andrisano

University of Bologna

Publications: 16

İlhami Gülçin

İlhami Gülçin

Atatürk University

Publications: 16

Parham Taslimi

Parham Taslimi

Bartin University

Publications: 15

Christopher M. Hadad

Christopher M. Hadad

The Ohio State University

Publications: 11

Trending Scientists

Jochen Teizer

Jochen Teizer

Aarhus University

Nina Berova

Nina Berova

Columbia University

Xujie Yang

Xujie Yang

Nanjing University of Science and Technology

Robert S. Weatherup

Robert S. Weatherup

University of Oxford

Hermes Mianzan

Hermes Mianzan

Spanish National Research Council

Kazuyuki Inubushi

Kazuyuki Inubushi

Chiba University

Andrey S. Shaw

Andrey S. Shaw

Genentech

Chwan-Chuen King

Chwan-Chuen King

National Taiwan University

Margarida Tomé

Margarida Tomé

University of Lisbon

Paul Vezina

Paul Vezina

University of Chicago

Andrew R. Mayer

Andrew R. Mayer

Mind Research Network

Jacques Van Snick

Jacques Van Snick

Ludwig Cancer Research

Melissa A. Cyders

Melissa A. Cyders

Indiana University – Purdue University Indianapolis

Anders Larsson

Anders Larsson

Uppsala University

Anthony M. Dart

Anthony M. Dart

The Alfred Hospital

Klaus-Peter Lesch

Klaus-Peter Lesch

University of Würzburg

Something went wrong. Please try again later.